Evidence map›Paper›PMID 37789211›Full record

ArticleAAPS PharmSciTech2023

Film Coatings Based on Aqueous Shellac Ammonium Salt "Swanlac

S Strich, H Azehaf, C Neut, Y Lellouche-Jacob, N Medkour, M Penning, Y Karrout

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in AAPS PharmSciTech, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

S StrichUniv. Lille, Inserm, CHU Lille, U1008, F-59000, Lille, France.
H AzehafUniv. Lille, Inserm, CHU Lille, U1008, F-59000, Lille, France.
C NeutUniv. Lille, Inserm, CHU Lille, U1286_INFINITE, F-59000, Lille, France.
Y Lellouche-JacobUniv. Lille, Inserm, CHU Lille, U1008, F-59000, Lille, France.
N MedkourUniv. Lille, Inserm, CHU Lille, U1008, F-59000, Lille, France.
M PenningPennConsult, Wormser Straße 28, 55276, Oppenheim, Germany.
Y KarroutUniv. Lille, Inserm, CHU Lille, U1008, F-59000, Lille, France. youness.karrout@univ-lille.fr.ORCID http://orcid.org/0000-0002-9037-8490
Inserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past decades, increasing interests took place in the realm of drug delivery systems. Beyond treating intestinal diseases such as inflammatory bowel disease, colon targeting can provide possible applications for oral administration of proteins as well as vaccines due to the lower enzymatic activity in the distal part of GIT. To date, many strategies are employed to reach the colon. This article encompasses different biomaterials tested as film coatings and highlights appropriate formulations for colonic drug delivery. A comparison of different films was made to display the most interesting drug release profiles. These films contained ethylcellulose, as a thermoplastic polymer, blended with an aqueous shellac ammonium salt solution. Different blend ratios were selected as well for thin films as for coated mini-tablets, mainly varying as follows: (80:20); (75:25); (60:40). The impact of blend ratio and coating level was examined as well as the addition of natural polysaccharide "inulin" to target the colon. In vitro drug release was measured in 0.1 M HCl for 2 h followed by phosphate buffer saline pH 6.8 to simulate gastric and intestinal fluids, respectively. Coated mini-tablets were exposed to fresh fecal samples of humans in order to simulate roughly colonic content. Several formulations were able to fully protect theophylline as a model drug up to 8 h in the upper GIT, but allowing for prolonged release kinetics in the colon. These very interesting colonic release profiles were related to the amount of the natural polysaccharide added into the system.

Indexed as

ColonInulinDrug Delivery SystemsHumansPolysaccharidesResins, PlantTabletsWaterInulinPolysaccharidesResins, PlantshellacTabletsWateraqueous shellac salt solutioncolon targetingfilm coatingsinulinoral controlled releasereservoir systems

Identifiers

PMID37789211
OpenAlexW4387312556

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.